Deciphera Pharmaceuticals LLC (DCPH) Insider Trading
- $51,456,028.00
- $64,250,850.79
- June 16, 2023
- Michael Douglas Taylor
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
June 16, 2023 | EVP | 1,655 | $14.40 | Sell | $23,832.00 | |
June 16, 2023 | Insider | 1,238 | $14.40 | Sell | $17,827.20 | |
June 8, 2023 | Director | 10,000 | $13.88 | Buy | $138,800.00 | |
May 10, 2023 | Director | 11,000 | $13.86 | Buy | $152,460.00 | |
March 21, 2023 | CEO | 7,500 | $15.57 | Sell | $116,775.00 | |
Feb. 16, 2023 | CFO | 1,370 | $15.10 | Sell | $20,687.00 | |
Feb. 16, 2023 | EVP | 971 | $15.10 | Sell | $14,662.10 | |
Feb. 16, 2023 | Insider | 1,159 | $15.10 | Sell | $17,500.90 | |
Jan. 24, 2023 | Major Shareholder | 1,666,666 | $18.00 | Buy | $29,999,988.00 | |
Jan. 17, 2023 | Insider | 2,403 | $21.24 | Sell | $51,039.72 | |
Oct. 3, 2022 | EVP | 2,587 | $18.73 | Sell | $48,454.51 | |
June 16, 2022 | Insider | 1,298 | $10.75 | Sell | $13,953.50 | |
June 16, 2022 | EVP | 1,768 | $10.75 | Sell | $19,006.00 | |
April 29, 2022 | Major Shareholder | 1,478,978 | $10.00 | Buy | $14,789,780.00 | |
Feb. 16, 2022 | CFO | 1,368 | $9.05 | Sell | $12,380.40 | |
Feb. 16, 2022 | Insider | 1,366 | $9.05 | Sell | $12,362.30 | |
Feb. 16, 2022 | EVP | 984 | $9.05 | Sell | $8,905.20 | |
Oct. 4, 2021 | EVP | 2,659 | $33.17 | Sell | $88,199.03 | |
April 19, 2021 | Director | 5,300 | $46.26 | Sell | $245,178.00 | |
April 12, 2021 | Director | 14,700 | $43.84 | Sell | $644,448.00 | |
April 1, 2021 | Director | 8,000 | $45.57 | Sell | $364,560.00 | |
Jan. 4, 2021 | Director | 19,000 | $56.45 | Sell | $1,072,550.00 | |
Dec. 1, 2020 | Director | 19,000 | $60.90 | Sell | $1,157,100.00 | |
Sept. 10, 2020 | CFO | 3,000 | $47.71 | Sell | $143,130.00 | |
Sept. 8, 2020 | CFO | 6,000 | $45.49 | Sell | $272,940.00 | |
July 9, 2020 | Director | 23,541 | $54.99 | Sell | $1,294,519.59 | |
July 6, 2020 | Director | 27,544 | $55.22 | Sell | $1,520,979.68 | |
July 2, 2020 | Director | 48,245 | $56.69 | Sell | $2,735,009.05 | |
June 5, 2020 | Director | 5,635 | $55.90 | Sell | $314,996.50 | |
June 3, 2020 | Director | 6,365 | $59.14 | Sell | $376,426.10 | |
May 11, 2020 | CFO | 12,000 | $55.19 | Sell | $662,280.00 | |
April 28, 2020 | Director | 25,000 | $56.90 | Sell | $1,422,500.00 | |
April 17, 2020 | Director | 23,892 | $46.67 | Sell | $1,115,039.64 | |
April 14, 2020 | Director | 1,108 | $46.71 | Sell | $51,754.68 | |
April 9, 2020 | Director | 23,542 | $43.83 | Sell | $1,031,845.86 | |
April 1, 2020 | Director | 75,000 | $37.57 | Sell | $2,817,750.00 | |
Jan. 24, 2020 | Director | 25,000 | $66.13 | Sell | $1,653,250.00 | |
Jan. 22, 2020 | Insider | 26,999 | $67.18 | Sell | $1,813,792.82 | |
Jan. 15, 2020 | Insider | 12,023 | $65.23 | Sell | $784,260.29 | |
Jan. 7, 2020 | Insider | 1,650 | $60.02 | Sell | $99,033.00 | |
Jan. 3, 2020 | Director | 31,422 | $57.31 | Sell | $1,800,794.82 | |
Jan. 3, 2020 | CFO | 4,359 | $57.35 | Sell | $249,988.65 | |
Jan. 2, 2020 | Insider | 16,137 | $58.55 | Sell | $944,821.35 | |
Dec. 12, 2019 | Insider | 15,034 | $60.00 | Sell | $902,040.00 | |
Dec. 3, 2019 | Insider | 15,034 | $51.38 | Sell | $772,446.92 | |
Nov. 11, 2019 | Insider | 152,927 | $48.91 | Sell | $7,479,659.57 | |
Nov. 1, 2019 | Director | 25,000 | $46.16 | Sell | $1,154,000.00 | |
Oct. 28, 2019 | Insider | 29,820 | $44.34 | Sell | $1,322,218.80 | |
Oct. 28, 2019 | CFO | 3,750 | $44.34 | Sell | $166,275.00 | |
Sept. 19, 2019 | Insider | 3,000 | $35.56 | Sell | $106,680.00 |
Insiders are both buying and selling Deciphera Pharmaceuticals LLC stock.
The insider traders at Deciphera Pharmaceuticals LLC are: Michael Douglas Taylor, Thomas Patrick Kelly, James Arthur Bristol, Daniel Lee Flynn, Matthew L Sherman, Christopher John Morl, Daniel C Martin, Patricia L Allen, New Leaf Venture Management Ii, Jama Pitman, Brightstar Associates Llc, Dennis Leo Walsh, Franklin Stuart Friedman, and Steven L. Hoerter
The most active insider trader at Deciphera Pharmaceuticals LLC is Michael Douglas Taylor with 16 trades.
New Leaf Venture Management Ii has sold the most Deciphera Pharmaceuticals LLC stock with a total value of $25,494,000.00.
Brightstar Associates Llc has bought the most Deciphera Pharmaceuticals LLC stock with a total value of $74,789,756.00.
The most recent insider trade for Deciphera Pharmaceuticals LLC was on June 16, 2023.
The single biggest insider buy for Deciphera Pharmaceuticals LLC was from Brightstar Associates Llc with a total value of $29,999,988.00 on Jan. 24, 2023.
The single biggest insider sell for Deciphera Pharmaceuticals LLC was from New Leaf Venture Management Ii with a total value of $12,747,000.00 on Aug. 16, 2019.